Barrow Robert
Definium Therapeutics, Inc. · Chief Executive Officer
Barrow Robert is listed in filings as Chief Executive Officer at Definium Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 22, 2026, including sale activity and purchase activity. Recent filings connect the profile to Definium Therapeutics, Inc. (DFTX). The current snapshot covers public activity from Jun 25, 2024 to Jun 22, 2026. Reported amounts are shown as $113.1K to $3.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $113k15.7k shares | SellJun 25, 2024 | $7.22 | $45.98 | |
| $3.2k500 shares | BuyAug 19, 2024 | $6.31 | $45.98 | |
| $3.1k500 shares | BuyAug 20, 2024 | $6.12 | $45.98 | |
| $118k19.8k shares | SellSep 25, 2024 | $5.98 | $45.98 | |
| $142k19.1k shares | SellDec 26, 2024 | $7.43 | $45.98 | |
| $143k21.2k shares | SellMar 25, 2025 | $6.74 | $45.98 | |
| $180k26.5k shares | SellJun 25, 2025 | $6.80 | $45.98 | |
| $252k25.8k shares | SellSep 25, 2025 | $9.77 | $45.98 | |
| $339k25.8k shares | SellDec 26, 2025 | $13.15 | $45.98 |